Company intelligence / Profile preview

GenCefe Biotech

Ownership: Private
Development stage: Other

Overview

GenCefe Biotech provides integrated CRO services focused on molecular biology technologies such as high-throughput gene/oligonucleotide/protein synthesis. The company serves global researchers in biomedical R&D including cell/gene therapy development and vaccine research. It has established partnerships to expand distribution internationally (e.g., Pakistan with Bionics; Italy with Prodotti Gianni). No proprietary clinical results as it does not develop its own therapeutics.

Modalities: OligonucleotideGene synthesisProtein synthesis (including recombinant protein and cell-free protein synthesis)In vitro diagnostic reagents
Industry: Drug Discovery Services

Partnerships

Bionics (Pakistan distributor)Prodotti Gianni Srl (Italy distributor)

Beyond the preview

Go deeper on GenCefe Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenCefe Biotech.

Explore the full profile